Literature DB >> 17253549

Cognitive behavioural therapy for tinnitus.

P Martinez Devesa1, A Waddell, R Perera, M Theodoulou.   

Abstract

BACKGROUND: Tinnitus is an auditory perception that can be described as the experience of sound, in the ear or in the head, in the absence of external acoustic stimulation (not usually audible to anyone else). At present no specific therapy for tinnitus is acknowledged to be satisfactory in all patients. Cognitive behavioural therapy (CBT) uses relaxation, cognitive restructuring of the thoughts and exposure to exacerbating situations in order to promote habituation and may benefit tinnitus patients, as may the treatment of associated psychological conditions.
OBJECTIVES: To assess whether cognitive behavioural therapy is effective in the management of patients suffering from tinnitus. SEARCH STRATEGY: Our search included the Cochrane ENT Group Trials Register, the Cochrane Central Register of Controlled Trials (CENTRAL) (The Cochrane Library Issue 2, 2006), MEDLINE and EMBASE. The last search date was June 2006. SELECTION CRITERIA: Randomised controlled trials in which patients with unilateral or bilateral tinnitus as main symptom received cognitive behavioural treatment. DATA COLLECTION AND ANALYSIS: One review author (PMD) assessed every report identified by the search strategy. The four review authors assessed the methodological quality, applied inclusion/exclusion criteria and extracted data. MAIN
RESULTS: Six trials comprising 285 participants were included. 1. PRIMARY OUTCOME: subjective tinnitus loudness. CBT compared to a waiting list control group: we found no significant difference (Standardised Mean Difference (SMD) 0.06 (95% CI -0.25 to 0.37)). CBT compared to another intervention (Yoga, Education, Minimal Contact - Education and Education): we found no significant difference (SMD 0.1 (95% CI -0.22 to 0.42)).2. SECONDARY OUTCOMES: a) Depression. CBT compared to a waiting list control group: we found no significant difference in either group (SMD 0.29 (95%CI -0.04 to 0.63)). CBT compared to another intervention (Yoga, Education and Minimal Contact - Education): we found no significant difference (SMD 0.01 (95% CI -0.43 to 0.45)). b) Quality of life: CBT compared to a waiting list control group: we found a significant difference in favour of CBT versus the waiting list group (SMD 0.7 (95% CI 0.33 to 1.08)). CBT compared to another intervention (Education, Minimal Contact - Education and Education): we also found a significant difference between CBT and the other intervention control group (SMD 0.64 (95% CI 0.29 to 1.00)). There were no adverse/side effects reported in any trial. AUTHORS'
CONCLUSIONS: We did not find a significant difference in the subjective loudness of tinnitus, or in the associated depression. However we found a significant improvement in the quality of life (decrease of global tinnitus severity) of the participants, thus suggesting that cognitive behavioural therapy has an effect on the qualitative aspects of tinnitus and contributes positively to the management of tinnitus.

Entities:  

Mesh:

Year:  2007        PMID: 17253549     DOI: 10.1002/14651858.CD005233.pub2

Source DB:  PubMed          Journal:  Cochrane Database Syst Rev        ISSN: 1361-6137


  24 in total

1.  [TRT and psychotherapy in the treatment of tinnitus].

Authors:  H Schaaf; U Gieler
Journal:  HNO       Date:  2010-10       Impact factor: 1.284

2.  Treatments for tinnitus.

Authors:  William Noble
Journal:  Trends Amplif       Date:  2008-07-17

3.  Long-term effects of the "Heidelberg Model of Music Therapy" in patients with chronic tinnitus.

Authors:  Heike Argstatter; Miriam Grapp; Elisabeth Hutter; Peter Plinkert; Hans Volker Bolay
Journal:  Int J Clin Exp Med       Date:  2012-08-22

Review 4.  Tinnitus Retraining Therapy (TRT) for tinnitus.

Authors:  John S Phillips; Don McFerran
Journal:  Cochrane Database Syst Rev       Date:  2010-03-17

5.  Pilot study to evaluate ecological momentary assessment of tinnitus.

Authors:  James A Henry; Gino Galvez; Mitchel B Turbin; Emily J Thielman; Garnett P McMillan; Joseph A Istvan
Journal:  Ear Hear       Date:  2012 Mar-Apr       Impact factor: 3.570

6.  Methodological aspects of clinical trials in tinnitus: a proposal for an international standard.

Authors:  Michael Landgrebe; Andréia Azevedo; David Baguley; Carol Bauer; Anthony Cacace; Claudia Coelho; John Dornhoffer; Ricardo Figueiredo; Herta Flor; Goeran Hajak; Paul van de Heyning; Wolfgang Hiller; Eman Khedr; Tobias Kleinjung; Michael Koller; Jose Miguel Lainez; Alain Londero; William H Martin; Mark Mennemeier; Jay Piccirillo; Dirk De Ridder; Rainer Rupprecht; Grant Searchfield; Sven Vanneste; Florian Zeman; Berthold Langguth
Journal:  J Psychosom Res       Date:  2012-06-22       Impact factor: 3.006

7.  A model of caregiving through the end of life: seeking normal.

Authors:  Janice Penrod; Judith E Hupcey; Peggy Z Shipley; Susan J Loeb; Brenda Baney
Journal:  West J Nurs Res       Date:  2011-03-14       Impact factor: 1.967

8.  The Tinnitus Research Initiative (TRI) database: a new approach for delineation of tinnitus subtypes and generation of predictors for treatment outcome.

Authors:  Michael Landgrebe; Florian Zeman; Michael Koller; Yvonne Eberl; Markus Mohr; Jean Reiter; Susanne Staudinger; Goeran Hajak; Berthold Langguth
Journal:  BMC Med Inform Decis Mak       Date:  2010-08-03       Impact factor: 2.796

9.  Disagreements in meta-analyses using outcomes measured on continuous or rating scales: observer agreement study.

Authors:  Britta Tendal; Julian P T Higgins; Peter Jüni; Asbjørn Hróbjartsson; Sven Trelle; Eveline Nüesch; Simon Wandel; Anders W Jørgensen; Katarina Gesser; Søren Ilsøe-Kristensen; Peter C Gøtzsche
Journal:  BMJ       Date:  2009-08-13

10.  Efficacy and safety of bilateral continuous theta burst stimulation (cTBS) for the treatment of chronic tinnitus: design of a three-armed randomized controlled trial.

Authors:  Carola Arfeller; Reinhard Vonthein; Stefan K Plontke; Christian Plewnia
Journal:  Trials       Date:  2009-08-21       Impact factor: 2.279

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.